Glycemic control in cardiac surgery: rationale and current evidence

Area of Science:

• Cardiology
• Endocrinology
• Critical Care Medicine

Background:

• Hyperglycemia is associated with increased sepsis, mediastinitis, prolonged mechanical ventilation, arrhythmias, and extended intensive care and hospital stays in cardiac surgical patients.
• Significant controversy exists regarding appropriate glycemic management strategies, including definitions of hyperglycemia/hypoglycemia and initiation thresholds for therapy.
• The concept of "tight glycemic control" in this population yields conflicting evidence, contributing to ongoing debate.

Purpose of the Study:

• To review the existing literature on glycemic control in cardiac surgical patients.
• To highlight the controversies surrounding the definition and management of hyperglycemia and hypoglycemia.
• To discuss the conflicting evidence regarding tight glycemic control.

Main Methods:

• Literature review of studies involving cardiac surgical patients and glycemic management.
• Analysis of definitions of hyperglycemia and hypoglycemia across different studies.
• Examination of evidence for and against tight glycemic control.

Main Results:

• Association between hyperglycemia and adverse outcomes (sepsis, mediastinitis, prolonged ventilation, arrhythmias, longer ICU/hospital stay) confirmed.
• Lack of consensus on optimal blood glucose targets and intervention thresholds.
• Conflicting results from studies evaluating tight glycemic control.

Conclusions:

• The definition of hyperglycemia and hypoglycemia, along with target blood glucose levels for intervention, require standardization.
• Further research with consistent methodologies is needed to resolve the debate on tight glycemic control in cardiac surgery.
• Standardized definitions and consistent study designs are crucial for advancing glycemic management in this patient group.